Kurve Technology offers pharmaceutical companies versatile, cost-effective and compact
nasal drug delivery devices for local, systemic, and nose-to-brain medical therapies.
Invented by a long-time rhinosinusitis and allergy-sufferer, Kurve's nasal drug delivery
technologies offer an effective way to deliver both small and large molecule formulations.
Controlled Particle Dispersion is a
patented technology. Kurve continues to broaden its intellectual property
portfolio in drug delivery technologies by expanding patent claims and by
performing clinical trials at leading academic institutions.
